MARA Holdings
MARA
MicroStrategy
MSTR
Tesla
TSLA
Coinbase
COIN
Amazon
AMZN
US Stock MarketDetailed Quotes
AVIR Atea Pharmaceuticals
- 3.520
- +0.100+2.92%
Close Jan 3 16:00 ET
- 3.550
- +0.030+0.85%
Post 20:01 ET
297.31MMarket Cap-1.70P/E (TTM)
3.599High3.460Low282.22KVolume3.460Open3.420Pre Close1.00MTurnover0.44%Turnover RatioLossP/E (Static)84.46MShares4.60052wk High0.65P/B227.64MFloat Cap2.75052wk Low--Dividend TTM64.67MShs Float94.174Historical High--Div YieldTTM4.06%Amplitude2.750Historical Low3.545Avg Price1Lot Size
About Atea Pharmaceuticals Company
Atea Pharmaceuticals, Inc. is a clinical stage company, which focuses on discovering, developing, and commercializing antiviral therapeutics. Its product pipelines include Coronaviridae, Flaviviridae, and Paramyxovirdae. The company was founded by Jean-Pierre Sommadossi and David Chu in July 2012 and is headquartered in Boston, MA.
Company Profile
SymbolAVIR
Company NameAtea Pharmaceuticals
Listing DateOct 30, 2020
Issue Price24.00
Founded2012
CEODr. Jean-Pierre Sommadossi,PhD
MarketNASDAQ
Employees75
Fiscal Year Ends12-31
Address225 Franklin Street,Suite 2100
CityBoston
ProvinceMassachusetts
CountryUnited States of America
Zip Code02110
Phone1-857-284-8891
Websitehttp://www.ateapharma.com
Company Executives
- Name
- Position
- Salary
- Dr. Jean-Pierre Sommadossi,PhD
- President, Chief Executive Officer and Chairman of the Board
- 5.93M
- John Vavricka
- Chief Commercial Officer
- --
- Dr. Janet Hammond, M.D.,PhD
- Chief Development Officer
- 2.11M
- Dr. Maria Arantxa Horga, M.D.
- Chief Medical Officer
- 1.85M
- Andrea J. Corcoran
- Chief Financial Officer, Executive Vice President, Legal and Secretary
- 1.96M
- Wayne Foster
- Executive Vice President, Finance and Chief Accounting Officer
- 1.52M
- Barbara G. Duncan
- Independent Director
- 332.10K
- Jerome M. Ada M.D.
- Independent Director
- 442.10K
- Bruno Lucidi
- Independent Director
- 324.60K
- Dr. Bruce Polsky, M.D.
- Independent Director
- 324.60K
- Franklin M. Berger, C.F.A.
- Lead Independent Director
- 357.10K
- Dr. Polly A. Murphy, D.V.M.,PhD
- Independent Director
- 327.10K
Trending US Stocks
Fed Rate Cut Beneficiaries Fed Rate Cut Beneficiaries
Stocks that are expected to benefit from a Federal Reserve rate cut. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only.
This section presents the top 5 stocks in Fed Rate Cut Beneficiaries, ranked from highest to lowest based on real-time market data. Stocks that are expected to benefit from a Federal Reserve rate cut. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only.
This section presents the top 5 stocks in Fed Rate Cut Beneficiaries, ranked from highest to lowest based on real-time market data.